Evidence

Tissue details and study results are not published.

• About half

  Share of the Cincinnati Children's placement spent on Flex v2 work

  Note

  Owner's estimate; no time log.

  owner statement 2026-10-21 checked 21 Oct 2026

  cited

• Protocol, samples, custom probes and analysis

  Prepared the protocol, samples and custom probes, and ran the data analysis for Flex v2

  Note

  Owner statement for the Flex v2 work at Cincinnati Children's Research Foundation.

  owner statement 2026-10-22 checked 22 Oct 2026

  cited

• 88

  Samples run through the full Flex v2 protocol

  owner statement 2026-10-22 checked 22 Oct 2026

  cited

• Cell Ranger

  Software I used to analyze the Flex v2 sequencing data

  owner statement 2026-10-22 checked 22 Oct 2026

  cited

• Illumina

  Sequencing platform for the Flex v2 mouse study

  owner statement 2026-10-22 checked 22 Oct 2026

  cited

• Mouse study

  Study context for the Flex v2 samples

  owner statement 2026-10-22 checked 22 Oct 2026

  cited

• 80%

  Analysis-time reduction from the Excel/VBA mass-spec macro

  Note

  Historical résumé claim; no baseline timing or measurement method is on file.

  Résumé, Research Student II and Mass-Spectrometry Data Automation checked 20 Oct 2026

  cited

• Mainly human samples

  Samples processed with the mass-spec macro

  Note

  The macro also supported samples from the same mouse study as the Flex v2 work. The 70+ animal-study sample figure belongs to the placement overall, not the macro.

  owner statement 2026-10-22 checked 22 Oct 2026

  cited

One SPRSound snapshot, from the validation report in the résumé. Counts only; no accuracy claim.

• 6,567

  Source recordings checked in the SPRSound snapshot

  measured

• 24,578

  Event annotations checked

  measured

• 6,566

  Canonical recordings kept after resolving one conflicting duplicate

  Note

  Source aliases and annotations are kept.

  measured

• 5,881

  Recordings eligible for supervised training

  measured

• 854

  Known subjects among the eligible recordings

  measured

• 598

  Train split, counted in subjects

  Note

  Split by subject.

  measured

• 128

  Validation split, counted in subjects

  Note

  Split by subject.

  measured

• 128

  Test split, counted in subjects

  Note

  Split by subject; 598 + 128 + 128 = 854.

  measured

• 0

  Subjects or identical PCM audio shared between splits

  Note

  Source: v0.11.3 validation report.

  measured

• 9600 baud

  Serial speed between Arduino and Processing

  Arduino source (Serial.begin(9600))

  cited

• 450

  Beat-detection threshold in the Processing monitor

  Note

  A raw ADC count hard-coded in the source: a fixed threshold with no adaptive detection.

  Processing source (threshold = 450)

  cited

• A1

  Analog input used on the Ninetales board

  Arduino source (ECG_PIN = A1)

  cited

• about 100 Hz

  Nominal sampling rate from a 10 ms loop delay

  Note

  Nominal: the 10 ms delay plus conversion and serial time.

  Arduino source (delay(10)), Résumé

  target

• 3 of 3

  Static load tests, insert unaffected (30 lb for 1 minute)

  Note

  Small bench test on one prototype. It gives no statistical or clinical result.

  Final report, Verification Testing / Results

  measured

• 2 of 3

  Impact tests, insert unaffected (30 lb dropped from 1 ft)

  Note

  Small bench test on one prototype.

  Final report, Verification Testing / Results

  measured

• V2 (beta)

  Prototype iteration we built

  Note

  The final report calls V2 a functional alpha; the résumé calls it a beta. V1 used cardboard and foam.

  Final report, Prototype journey, Résumé

  measured

• 5 to 7 years

  Target users: children aged 5 to 7 with symptomatic pes planus

  Note

  The intended population. No pediatric clinical study was run.

  Final report, problem statement, Résumé, Pediatric Arch Support

  cited

• 0 built

  V3 built

  Note

  V3 (custom-molded hybrid inserts, reinforced pouch) was planned and handed to a future team. It was not built.

  Final report, Technical Memo, Résumé

  ongoing

• 10%

  Room for up to 10% volumetric foot growth

  Note

  Design target. The report lists tensile-strain testing and compression mapping as planned methods and gives no result.

  Final report, sections 1 and requirements table

  target

• 150 N

  Target ground-reaction load

  Note

  Design target. Our static test used a 30 lb load for 1 minute, which does not verify 150 N.

  Final report, requirements table

  target

• < 8 mm

  Midfoot thickness under 8 mm

  Note

  Design target. The report lists caliper measurement as the planned method and gives no measured thickness.

  Final report, requirements table

  target

• 1 of 3

  Third impact test: insert slightly damaged, gel partly contained, slight leakage

  Note

  The report says slight damage and slight leakage, with no rupture. The pass criterion was an insert that stays fully intact. The result points at gel containment.

  Final report, Verification Testing / Results, Résumé

  noted

• 8

  API providers configured in the collector

  Note

  Count of provider definitions in one source file; the collector rule allows official public APIs only.

  measured

• 28

  Database tables in the accounts database

  Note

  Count of CREATE TABLE statements in schema.sql. The job-data database adds 19 more.

  measured

• 27

  Participants with obesity and no associated metabolic disorder (paper)

  Note

  Reported in the paper; I contributed to sample collection and processing.

  IJMS paper, Abstract

  cited

• 15

  Lean healthy controls (paper)

  Note

  Reported by the paper.

  IJMS paper, Abstract

  cited

• 184

  Proteins measured on an Olink panel (paper)

  Note

  Panel size as reported by the paper.

  IJMS paper, Abstract

  cited

• 24

  Differentially expressed proteins (paper)

  Note

  The paper reports 13 lower and 11 higher proteins in the obesity group.

  IJMS paper, Abstract

  cited

• 711

  Serum metabolites kept after quality control (preprint)

  Note

  Preprint, not peer-reviewed. Reported differences were not corrected for multiple testing and remain exploratory.

  Preprint, Methods

  cited

• 50+

  Endocrine research samples processed at iTRI

  Note

  Source: résumé.

  Résumé, Clinical Research Assistant

  cited

• 4

  Incoming team members I trained

  Note

  Source: résumé.

  Résumé, Clinical Research Assistant

  cited

• about 60

  Residents in my Resident Advisor community

  Note

  Approximate figure from earlier résumé records.

  Résumé, Resident Advisor

  cited

• over 100

  Cumulative attendance at events I planned

  Note

  Figure from earlier résumé records.

  Résumé, Resident Advisor

  cited

• 2 (2022, 2023)

  FIRST Global Challenge world events attended for Qatar

  Note

  Geneva, Switzerland, 2022; Singapore, 2023. Documented in résumé.

  Résumé, FIRST Robotics

  cited

• Aug 2026

  Live Well co-op start

  Note

  Ongoing; no end date set.

  ongoing